Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma
2005; Wiley; Volume: 78; Issue: 4 Linguagem: Inglês
10.1002/ajh.20303
ISSN1096-8652
AutoresYukihiro Arai, Jiro Tadokoro, Kinuko Mitani,
Tópico(s)CNS Lymphoma Diagnosis and Treatment
ResumoAmerican Journal of HematologyVolume 78, Issue 4 p. 317-318 Letters and CorrespondenceFree Access Ventricular tachycardia associated with infusion of rituximab in mantle cell lymphoma Yukihiro Arai, Yukihiro Arai Department of Hematology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorJiro Tadokoro, Jiro Tadokoro Department of Hematology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorKinuko Mitani, Kinuko Mitani Department of Hematology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this author Yukihiro Arai, Yukihiro Arai Department of Hematology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorJiro Tadokoro, Jiro Tadokoro Department of Hematology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this authorKinuko Mitani, Kinuko Mitani Department of Hematology, Dokkyo University School of Medicine, Tochigi, JapanSearch for more papers by this author First published: 28 March 2005 https://doi.org/10.1002/ajh.20303Citations: 23AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat REFERENCES 1Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 235– 242. 2Lowndes S, Darby A, Mead G, Lister A. Stevens-Johnson syndrome after treatment with rituximab. Ann Oncol 2002; 13: 1948– 1950. 3Burton C, Kaczmarski R, Jan-Mohamed R. Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003; 348: 2690– 2691. 4Kunkel L, Wong A, Maneatis T, et al. Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit–risk update. Semin Oncol 2000; 27: 53– 61. 5Foran JM, Rohatiner AZS, Cunningham D, et al. European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol 2000; 18: 317– 324. Citing Literature Volume78, Issue4April 2005Pages 317-318 ReferencesRelatedInformation
Referência(s)